Cargando…
Smoking cessation: an economic analysis and review of varenicline
Despite efforts to decrease tobacco use, smoking continues to be a leading cause of preventable morbidity and premature death. The associated economic burden is substantial, both in the form of direct costs (healthcare expenditures) and indirect costs (lost productivity), regardless of whether the b...
Autor principal: | Faulkner, Michele A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3169991/ https://www.ncbi.nlm.nih.gov/pubmed/21935304 |
Ejemplares similares
-
Smoking cessation therapy with varenicline
por: Mohanasundaram, Uma M, et al.
Publicado: (2008) -
Smoking cessation in Asians: focus on varenicline
por: Xiao, Dan, et al.
Publicado: (2015) -
Varenicline for smoking cessation: efficacy, safety, and treatment recommendations
por: Ebbert, Jon O, et al.
Publicado: (2010) -
Smoking cessation in Asians: focus on varenicline [Corrigendum]
Publicado: (2015) -
Tobacco smoking cessation management: integrating varenicline in current practice
por: Galanti, Laurence M
Publicado: (2008)